BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 38862971)

  • 1. BATF promotes tumor progression and association with FDG PET-derived parameters in colorectal cancer.
    Lu X; Liu J; Feng L; Huang Y; Xu Y; Li C; Wang W; Kan Y; Yang J; Zhang M
    J Transl Med; 2024 Jun; 22(1):558. PubMed ID: 38862971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive Value of Metabolic Parameters Derived From
    Liu H; Ye Z; Yang T; Xie H; Duan T; Li M; Wu M; Song B
    Front Immunol; 2021; 12():724464. PubMed ID: 34512653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated tumor-to-liver uptake ratio (TLR) from
    Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer.
    Gu J; Yamamoto H; Fukunaga H; Danno K; Takemasa I; Ikeda M; Tatsumi M; Sekimoto M; Hatazawa J; Nishimura T; Monden M
    Dig Dis Sci; 2006 Dec; 51(12):2198-205. PubMed ID: 17080242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-induced modulation of glucose transporter expression impacts
    Xia H; Chen J; Gao H; Kong SN; Deivasigamani A; Shi M; Xie T; Hui KM
    Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):787-797. PubMed ID: 31832727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Uptake on Preoperative Positron Emission Tomography/Computed Tomography in the Lymph Nodes of Patients with Primary Colorectal Cancer.
    Sasaki K; Kawasaki H; Sato M; Koyama K; Yoshimi F; Nagai H
    Dig Surg; 2017; 34(1):60-67. PubMed ID: 27454870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between glucose metabolism parameters derived from FDG and tumor TNM stages and metastasis-associated proteins in colorectal carcinoma patients.
    Zhang M; Yang J; Jiang H; Jiang H; Wang Z
    BMC Cancer; 2021 Mar; 21(1):258. PubMed ID: 33750337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4'-[methyl-
    Fukuda Y; Yamamoto Y; Mitamura K; Ishikawa R; Asano E; Toyohara J; Norikane T; Nishiyama Y
    Ann Nucl Med; 2019 Nov; 33(11):822-827. PubMed ID: 31401773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of [
    Jiang H; Zhang R; Jiang H; Zhang M; Guo W; Feng G; Pan W; Xu H; Wang S
    Nucl Med Biol; 2019; 72-73():36-44. PubMed ID: 31330410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Significance of
    Zheng H; Cui Y; Li X; Du B; Li Y
    Clin Lung Cancer; 2019 Nov; 20(6):420-428. PubMed ID: 31300363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ¹⁸F-fluoro-2-deoxyglucose uptake on PET CT and glucose transporter 1 expression in colorectal adenocarcinoma.
    Hong R; Lim SC
    World J Gastroenterol; 2012 Jan; 18(2):168-74. PubMed ID: 22253523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using dual-tracer PET to predict the biologic behavior of human colorectal cancer.
    Wang H; Zhang J; Tian J; Qu B; Li T; Chen Y; Liu J; Wang S
    J Nucl Med; 2009 Nov; 50(11):1857-64. PubMed ID: 19837754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic role of metabolic 18F-FDG PET/CT parameters and hematological prognostic indicators in patients with colorectal cancer.
    Cengiz A; Yersal Ö; Ömürlü İK; Yürekli Y
    Indian J Cancer; 2023; 60(2):224-229. PubMed ID: 37530245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of CT, FDG PET-CT and serum tumor markers in staging recurrent colorectal cancer.
    Caglar M; Yener C; Karabulut E
    Int J Comput Assist Radiol Surg; 2015 Jul; 10(7):993-1002. PubMed ID: 25213271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between
    Liu X; Wang SC; Ni M; Xie Q; Zhang YF; Lv WF; Geng GY
    Abdom Radiol (NY); 2022 Apr; 47(4):1255-1264. PubMed ID: 35138462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The correlation of
    Qu YH; Long N; Ran C; Sun J
    Clin Transl Oncol; 2021 Mar; 23(3):620-627. PubMed ID: 32683540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography for the detection of proximal synchronous lesions in patients with obstructive colorectal cancer.
    Kim WS; Lee HS; Lee JM; Kwak MS; Hwang SW; Park SH; Yang DH; Kim KJ; Myung SJ; Yang SK; Byeon JS
    J Gastroenterol Hepatol; 2017 Feb; 32(2):401-408. PubMed ID: 27418280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidental focal colorectal ¹⁸F-fluorodeoxyglucose uptake on positron emission tomography/computed tomography.
    Cho SH; Kim SW; Kim WC; Park JM; Yoo IeR; Kim SH; Oh ST
    World J Gastroenterol; 2013 Jun; 19(22):3453-8. PubMed ID: 23801838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of (18)F-fluorodeoxyglucose PET/CT findings with vascular endothelial growth factors and receptors in colorectal cancer.
    Kocael A; Vatankulu B; Şimşek O; Cengiz M; Kemik A; Kocael P; Halaç M; Sönmezoğlu K; Ulualp K
    Tumour Biol; 2016 Mar; 37(3):3871-7. PubMed ID: 26476536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of Intratumor Metabolic Heterogeneity Parameters on
    Liu X; Xiang K; Geng GY; Wang SC; Ni M; Zhang YF; Pan HF; Lv WF
    Contrast Media Mol Imaging; 2022; 2022():2586245. PubMed ID: 35173559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.